Final results of a phase 2 study of talazoparib (TALA) following platinum or multiple cytotoxic regimens in advanced breast cancer patients (pts) with germline BRCA1/2 mutations (ABRAZO) Meeting Abstract
| Authors: | Turner, N. C.; Telli, M. L.; Rugo, H. S.; Mailliez, A.; Ettl, J.; Grischke, E. M.; Mina, L. A.; Gelpi, J. B.; Fasching, P. A.; Hurvitz, S. A.; Wardley, A. M.; Chappey, C.; Verret, W.; Hannah, A. L.; Robson, M. E. |
| Abstract Title: | Final results of a phase 2 study of talazoparib (TALA) following platinum or multiple cytotoxic regimens in advanced breast cancer patients (pts) with germline BRCA1/2 mutations (ABRAZO) |
| Meeting Title: | 53rd Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 35 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2017 Jun 2-6 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2017-05-20 |
| Start Page: | 33s |
| Language: | English |
| ACCESSION: | WOS:000411895701144 |
| DOI: | 10.1200/JCO.2017.35.15_suppl.1007 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 1007 -- Source: Wos |
